DIN 02434806 — GAZYVA 25 MG
GAZYVA is a solution of Obinutuzumab marketed by HOFFMANN-LA ROCHE LIMITED. The full Obinutuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02434806
- Brand name
- GAZYVA
- Active ingredient
- Obinutuzumab
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Anti-CD20 monoclonal antibody (glycoengineered Type II)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.